Health Condition 1: A15-A19- Tuberculosis Health Condition 2: A180- Tuberculosis of bones and joints Health Condition 3: A181- Tuberculosis of genitourinary system Health Condition 4: A150- Tuberculosis of lung
Conditions
Interventions
None listed
Sponsors
RSSDI
Eligibility
Inclusion criteria
Inclusion criteria: All consecutive adults with tuberculosis infection determined bacteriologically, histologically or clinically were anti-tubercular drugs are planned to be prescribed would be recruited after informed consent
Exclusion criteria
Exclusion criteria: Patients with serious life threatening tuberculosis infection, previous diagnosis of diabetes mellitus, pregnant women, those on steroid therapy or planned for steroid therapy and those unwilling for study related diagnostic procedures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the most robust strategy and the best time for diagnosis of diabetes mellitus in patients with mycobacterium tuberculosisTimepoint: 1. At Diagnosis 2. Three month after Diagnosis 3. End of treatment patients | — |
Secondary
| Measure | Time frame |
|---|---|
| To ascertain clinical differences in presentation of tubercular infection in patients with diabetes and glucose intolerance compared to those with normal glucose toleranceTimepoint: At Diagnosis ;To determine prevalence of glucose intolerance (diabetes mellitus, prediabetes and transient hyperglycaemia) in patients with mycobacterium tuberculosisTimepoint: 1. At Diagnosis 2. Three month after Diagnosis 3. End of treatment;To determine treatment response and final outcomes in patients with tubercular infection and glucose intolerance compared to those with normal glucose toleranceTimepoint: End of treatment | — |
Countries
India
Contacts
Public ContactProf Jubbin Jagan Jacob
Christian Medical College and Hospital
Outcome results
None listed